These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 597565)

  • 21. Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay.
    Koch CA; Lasho TL; Tefferi A
    Br J Haematol; 2004 Oct; 127(1):34-9. PubMed ID: 15384975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vivo platelet activation in mild arterial hypertension].
    Guicheney P; Baudouin-Legros M; Meyer P
    Arch Mal Coeur Vaiss; 1987 Jun; 80(6):808-11. PubMed ID: 2959230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin levels in hypertension.
    Biondi ML; Agostoni A; Marasini B
    J Hypertens Suppl; 1986 Apr; 4(1):S39-41. PubMed ID: 3457903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders.
    Pareti FI; Gugliotta L; Mannucci L; Guarini A; Mannucci PM
    Thromb Haemost; 1982 Apr; 47(2):84-9. PubMed ID: 7101243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet function studies in myeloproliferative disorders.
    Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet phospholipids in thrombocytosis due to myeloproliferative disorders.
    Breuer JH; Harsányi V; Solti V; Hollán SR
    Haemostasis; 1981; 10(3):134-40. PubMed ID: 7262643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
    Yamamoto K; Sekiguchi E; Takatani O
    Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Classification of chronic psychoses types I and II and platelet serotonin levels. Apropos of 38 cases].
    Boudjema F; Terra JL; Guyotat J; Lemoine P; Renaud B; Flachaire E
    Encephale; 1985; 11(1):39-42. PubMed ID: 3996288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin uptake and efflux in blood platelets from untreated and neuroleptic-treated schizophrenics.
    Lingjaerde O
    Biol Psychiatry; 1983 Dec; 18(12):1345-56. PubMed ID: 6140960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Method of determination of bound and free serotonin in different biological media].
    Pliushkis Iu; Matulis AA; Murza VA
    Lab Delo; 1976; (2):84-8. PubMed ID: 58106
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet and plasma beta thromboglobulin in myeloproliferative syndromes and secondary thrombocytosis.
    Boughton BJ; Allington MJ; King A
    Br J Haematol; 1978 Sep; 40(1):125-32. PubMed ID: 81681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet abnormalities in myeloproliferative disorders.
    Holme S; Murphy S
    Clin Lab Med; 1990 Dec; 10(4):873-88. PubMed ID: 2272179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood platelet function in chronic myeloid-type diseases. I. Myeloproliferative diseases].
    Cieslar P; Matousová O
    Vnitr Lek; 1987 Nov; 33(11):998-1009. PubMed ID: 3439041
    [No Abstract]   [Full Text] [Related]  

  • 35. Serotonin as a factor involved in pathophysiology of thromboangiitis obliterans.
    Pietraszek MH; Choudhury NA; Baba S; Sakaguchi S; Hachiya T; Urano T; Takada Y; Takada A
    Int Angiol; 1993 Mar; 12(1):9-12. PubMed ID: 8376917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo platelet release in myeloproliferative disorders.
    Ireland H; Lane DA; Wolff S; Foadi M
    Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet and plasma serotonin concentrations in glomerulonephritis, II.
    Parbtani A; Frampton G; Cameron JS
    Clin Nephrol; 1980 Sep; 14(3):112-23. PubMed ID: 7418277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet Fc receptor. Increased expression in myeloproliferative disease.
    Moore A; Nachman RL
    J Clin Invest; 1981 Apr; 67(4):1064-71. PubMed ID: 6937475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
    Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA
    Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in distribution of platelet membrane glycoproteins in patients with myeloproliferative disorders.
    Bolin RB; Okumura T; Jamieson GA
    Am J Hematol; 1977; 3():63-71. PubMed ID: 602945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.